In the small trial, patients who were given the drug, known as Fevipiprant, had less inflammation in their airways. And some patients with uncontrolled asthma felt their symptoms improved.Charity Asthma UK said the research showed “massive promise and should be greeted with cautious optimism”. More than five million people in the UK have asthma, a long-term condition that affects the airways in the lungs and can cause a cough, wheezing and breathlessness.For most people the right treatment – for example, inhalers – can help control it, but some people have more persistent symptoms.

No Comments

Leave a Comment